Accès direct au contenu


Version française > Publications > Publications 2013

Publications 2013


Vaisse, B., J. J. Mourad, X. Girerd, O. Hanon, J. M. Halimi, and B. Pannier. 2013. [Flash Survey 2012: the use of self-measurement in France and its evolution since 2010]. Ann Cardiol Angeiol (Paris) 62:200.

Sautenet, B., A. Caille, J. M. Halimi, P. Goupille, and B. Giraudeau. 2013. Better reporting and greater homogeneity in outcome measures are seen in randomized trial protocols when guidelines exist. J Clin Epidemiol 66:838.

Sacher, F., V. Probst, P. Maury, D. Babuty, J. Mansourati, Y. Komatsu, C. Marquie, A. Rosa, A. Diallo, R. Cassagneau, C. Loizeau, R. Martins, M. E. Field, N. Derval, S. Miyazaki, A. Denis, A. Nogami, P. Ritter, J. B. Gourraud, S. Ploux, A. Rollin, A. Zemmoura, D. Lamaison, P. Bordachar, B. Pierre, P. Jais, J. L. Pasquie, M. Hocini, F. Legal, P. Defaye, S. Boveda, Y. Iesaka, P. Mabo, and M. Haissaguerre. 2013. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2. Circulation 128:1739.

Puisset, F., M. White-Koning, N. Kamar, A. Huart, F. Haberer, H. Blasco, C. Le Guellec, T. Lafont, A. Grand, L. Rostaing, E. Chatelut, and J. Pourrat. 2013. Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease. Br J Clin Pharmacol 76:734.

Muntean, D. M., V. Ordodi, R. Ferrera, and D. Angoulvant. 2013. Volatile anaesthetics and cardioprotection: lessons from animal studies. Fundam Clin Pharmacol 27:21.

Mewton, N., H. Thibault, F. Roubille, O. Lairez, G. Rioufol, C. Sportouch, I. Sanchez, C. Bergerot, T. T. Cung, G. Finet, D. Angoulvant, D. Revel, E. Bonnefoy-Cudraz, M. Elbaz, C. Piot, I. Sahraoui, P. Croisille, and M. Ovize. 2013. Postconditioning attenuates no-reflow in STEMI patients. Basic Res Cardiol 108:383.

Legendre, C. M., C. Licht, P. Muus, L. A. Greenbaum, S. Babu, C. Bedrosian, C. Bingham, D. J. Cohen, Y. Delmas, K. Douglas, F. Eitner, T. Feldkamp, D. Fouque, R. R. Furman, O. Gaber, M. Herthelius, M. Hourmant, D. Karpman, Y. Lebranchu, C. Mariat, J. Menne, B. Moulin, J. Nurnberger, M. Ogawa, G. Remuzzi, T. Richard, R. Sberro-Soussan, B. Severino, N. S. Sheerin, A. Trivelli, L. B. Zimmerhackl, T. Goodship, and C. Loirat. 2013. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med 368:2169.

Laurenty, A. P., F. Thomas, E. Chatelut, S. Betrian, C. Le Guellec, I. Hennebelle, S. Le Guellec, and C. Chevreau. 2013. Irreversible hepatotoxicity after administration of trabectedin to a pleiomorphic sarcoma patient with a rare ABCC2 polymorphism: a case report. Pharmacogenomics 14:1389.

Halimi, J. M. 2013. Low-grade proteinuria and microalbuminuria in renal transplantation. Transplantation 96:121.

Halimi, J. M. 2013. [ESH/ESC and French guidelines for the management of hypertension: Similarities and discrepancies]. Presse Med 42:1155.

Gatault, P., and Y. Lebranchu. 2013. Conversion to mTOR-inhibitor-based immunosuppression: which patients and when? Transplant Res 2:S3.

Fremeaux-Bacchi, V., F. Fakhouri, A. Garnier, F. Bienaime, M. A. Dragon-Durey, S. Ngo, B. Moulin, A. Servais, F. Provot, L. Rostaing, S. Burtey, P. Niaudet, G. Deschenes, Y. Lebranchu, J. Zuber, and C. Loirat. 2013. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol 8:554.

Fauchier, L., B. Pierre, N. Clementy, and D. Babuty. 2013. Non-antiarrhythmic drugs for the prevention of atrial fibrillation: ACEIs, ARBs, statins and PUFAs. J Med Liban 61:105.

Fauchier, L., M. A. Isorni, N. Clementy, B. Pierre, E. Simeon, and D. Babuty. 2013. Prognostic value of programmed ventricular stimulation in Brugada syndrome according to clinical presentation: an updated meta-analysis of worldwide published data. Int J Cardiol 168:3027.

Fauchier, L., N. Clementy, and D. Babuty. 2013. Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials. Curr Opin Cardiol 28:7.

Duicu, O. M., D. Angoulvant, and D. M. Muntean. 2013. Cardioprotection against myocardial reperfusion injury: successes, failures, and perspectives. Can J Physiol Pharmacol 91:657.

Clementy, N., N. Rebotier, and D. Babuty. 2013. Pacemaker "dysfunction" treated by radiofrequency ablation. Pacing Clin Electrophysiol 36:772.

Blacher, J., J. M. Halimi, O. Hanon, J. J. Mourad, A. Pathak, B. Schnebert, and X. Girerd. 2013. [Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension]. Ann Cardiol Angeiol (Paris) 62:132.

Bigot, A., G. Gusto, N. Copin, O. Lantieri, and J. M. Halimi. 2013. [Effect of coronary risk and of hypertension on renal risk in the general population]. Ann Cardiol Angeiol (Paris) 62:179.

Bernard, A., L. Fauchier, C. Pellegrin, N. Clementy, C. Saint Etienne, A. Banerjee, D. Naudin, and D. Angoulvant. 2013. Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation. Thromb Haemost 110:560.

Benhenda, N., A. Bernard-Brunet, M. Ferrandiere, E. Salame, and D. Babuty. 2013. Fatal short-coupled torsade de pointes in a patient with primary oxalosis. Intensive Care Med 39:1843.

Banerjee, A., L. Fauchier, P. Vourc'h, C. R. Andres, S. Taillandier, J. M. Halimi, and G. Y. Lip. 2013. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project. J Am Coll Cardiol 61:2079.

Banerjee, A., L. Fauchier, P. Vourc'h, C. R. Andres, S. Taillandier, J. M. Halimi, and G. Y. Lip. 2013. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation Project. Chest. 2013 Dec 19.

Chaigne B, Gatault P, Darrouzain F, Barbet C, Degenne D, François M, Szymanski P, Rabot N, Golea G, Diot E, Maillot F, Lebranchu Y, Nivet H, Paintaud G, Halimi JM, Guillevin L, Büchler M. Mycophenolate mofetil in patients with antineutrophil cytoplasmic antibody-associated vasculitis: a prospective pharmacokinetics and clinical study. Clin Exp Immunol. 2013 Dec 5

Longuet H, Sautenet B, Gatault P, Thibault G, Barbet C, Marliere JF, Halimi JM, Lebranchu Y, Baron C, Büchler M. Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation. Transpl Int. 2013 Nov 27

Saint Etienne C, Angoulvant D, Simeon E, Fauchier L. Antiplatelet therapy strategies after percutaneous coronary intervention in patients needing oral anticoagulation. Future Cardiol. 2013 Nov

Gatault P, Halimi JM, Forconi C, Thibault G, Barbet C, Mérieau E, Gaudy-Graffin C, Marlière JF, Goudeau A, Bruyère F, Lebranchu Y, Büchler M, Baron C. CMV Infection in the Donor and Increased Kidney Graft Loss: Impact of Full HLA-I Mismatch and Posttransplantation CD8+ Cell Reduction. Am J Transplant. 2013 Aug 13

Shabir S, Halimi JM, Cherukuri A, Ball S, Ferro C, Lipkin G, Benavente D, Gatault P, Baker R, Kiberd B, Borrows R. Predicting 5-Year Risk of Kidney Transplant Failure: A Prediction Instrument Using Data Available at 1 Year Posttransplantation. Am J Kidney Dis. 2013 Dec 31

Desestret V, Riou A, Chauveau F, Cho TH, Devillard E, Marinescu M, Ferrera R, Rey C, Chanal M, Angoulvant D, Honnorat J, Nighoghossian N, Berthezène Y, Nataf S, Wiart M. In vitro and in vivo models of cerebral ischemia show discrepancy in therapeutic effects of M2 macrophages. PLoS One. 2013 Jun

Zuber J, Grimbert P, Blancho G, Thaunat O, Durrbach A, Baron C, Lebranchu Y. Prognostic significance of graft Foxp3 expression in renal transplant recipients: a critical review and attempt to reconcile discrepancies. Nephrol Dial Transplant. 2013 May;28

Félix R, Crottès D, Delalande A, Fauconnier J, Lebranchu Y, Le Guennec JY, Velge-Roussel F. The Orai-1 and STIM-1 Complex Controls Human Dendritic Cell Maturation. PLoS One. 2013 May 20;8(5):e61595.

Granier A, Goulet O, Hoarau C. Fermentation products: immunological effects on human and animal models. Pediatr Res. 2013 May 13.

Roche-Nagle G, Bachynski K, Nathens AB, Angoulvant D, Rubin BB. Regionalization of services improves access to emergency vascular surgical care. Vascular. 2013 Apr

Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, Morelon E, Moal V, Janbon B, Alamartine E, Pouteil Noble C, Morel D, Kamar N, Buchler M, Mamzer MF, Peraldi MN, Hiesse C, Renoult E, Toupance O, Rerolle JP, Delmas S, Lang P, Lebranchu Y, Heng AE, Rebibou JM, Mousson C, Glotz D, Rivalan J, Thierry A, Etienne I, Moal MC, Albano L, Subra JF, Ouali N, Westeel PF, Delahousse M, Genin R, Hurault de Ligny B, Moulin B. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. J Clin Oncol. 2013 Apr 1

Büchler M, Longuet H, Lemoine R, Herr F, Gatault P, Thibault G, Ternant D, Foulon C, Pilorge B, Lemay D, Sung C, Halimi JM, Baron C, Lebranchu Y. Pharmacokinetic and pharmacodynamic studies of two different rabbit antithymocyte globulin dosing regimens: results of a randomized trial. Transpl Immunol. 2013 Mar;28(2-3):120-6.

Mirica SN, Duicu OM, Trancota SL, Fira-Mladinescu O, Angoulvant D, Muntean DM. Magnesium orotate elicits acute cardioprotection at reperfusion in isolated and in vivo rat hearts. Can J Physiol Pharmacol. 2013 Feb

Arbeille P, Angoulvant D, Zuj K, Patier J, Desveaux B, Quilliet L, Charbonnier B. Four-dimensional speckle tracking for assessing improvement in left ventricular contractility after coronary angioplasty. Ultrasound Med Biol. 2013 Jan


Zimmermann, H., S. Choquet, J. Moore, G. Salles, F. Morschhauser, T. Lamy, A. Jaccard, H. A. Horst, M. Leithauser, U. Duhrsen, P. Reinke, Y. Lebranchu, R. Neuhaus, H. Lehmkuhl, C. Tarella, P. Schlattmann, H. Riess, V. Leblond, and R. U. Trappe. 2013. Baseline differential blood count and prognosis in CD20-positive post-transplant lymphoproliferative disorder in the prospective PTLD-1 trial. Leukemia 27:2102.

Xu-Dubois, Y. C., A. Hertig, Y. Lebranchu, B. Hurault de Ligny, E. Thervet, M. Jaureguy, G. Touchard, P. Le Pogamp, Y. Le Meur, O. Toupance, A. E. Heng, F. Bayle, S. Girardot-Seguin, A. Servais, V. Meas-Yedid, and E. Rondeau. 2013. Progression of pulse pressure in kidney recipients durably exposed to CsA is a risk factor for epithelial phenotypic changes: an ancillary study of the CONCEPT trial. Transpl Int.






  • Facebook
  • twitter
  • google
  • imprimer
  • version PDF
  • Envoyer cette page

Retour au site institutionnel